로딩 중…
지수 로딩 중…
BioAge Labs, Inc.
BIOA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$20.77+3.90%
2026-06-18
Price Chart
BioAge Labs, Inc.+373.12%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $923M |
| Revenue | $10M |
| Net Income | $-90M |
| Total Assets | $398M |
| Net Assets | $379M |
| Value | |
| P/B | 2.44x |
| P/S | 89.50x |
| FCF Yield | -9.60% |
| Profitability | |
| ROE | -23.72% |
| ROA | -22.62% |
| Op. Margin | -985.93% |
| Revenue Growth | 91.04% |
| Financial Health | |
| Debt Ratio | 4.89% |
| Total Debt | $4M |
| FCF | $-89M |
| Cash | $242M |
| Current Ratio | 24.76x |
| Performance | |
| 1Y Return | 373.12% |
| 1M Return | 26.88% |
| From 52W High | -13.46% |
| 1Y MDD | -33.07% |
| Trading | |
| Volume | 596,652 shares |
| Trading Value | $12M |
| Per Share | |
| EPS | $-1.52 |
| BPS | $7.74 |